159 related articles for article (PubMed ID: 24939039)
1. Predictors of antiemetic alteration in pediatric acute myeloid leukemia.
Freedman JL; Faerber J; Kang TI; Dai D; Fisher BT; Huang YS; Li Y; Aplenc R; Feudtner C
Pediatr Blood Cancer; 2014 Oct; 61(10):1798-805. PubMed ID: 24939039
[TBL] [Abstract][Full Text] [Related]
2. A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center.
Aseeri M; Mukhtar A; Al Khansa S; Elimam N; Jastaniah W
J Oncol Pharm Pract; 2013 Jun; 19(2):138-44. PubMed ID: 23034405
[TBL] [Abstract][Full Text] [Related]
3. Impact of 5-HT(3) RA selection within triple antiemetic regimens on uncontrolled highly emetogenic chemotherapy-induced nausea/vomiting.
Schwartzberg L; Jackson J; Jain G; Balu S; Buchner D
Expert Rev Pharmacoecon Outcomes Res; 2011 Aug; 11(4):481-8. PubMed ID: 21711119
[TBL] [Abstract][Full Text] [Related]
4. Efficacy, safety and feasibility of fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in pediatric patients receiving moderately and highly emetogenic chemotherapy - results of a non-interventional observation study.
Willier S; Cabanillas Stanchi KM; von Have M; Binder V; Blaeschke F; Feucht J; Feuchtinger T; Döring M
BMC Cancer; 2019 Nov; 19(1):1118. PubMed ID: 31730451
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study.
Hilarius DL; Kloeg PH; van der Wall E; van den Heuvel JJ; Gundy CM; Aaronson NK
Support Care Cancer; 2012 Jan; 20(1):107-17. PubMed ID: 21258948
[TBL] [Abstract][Full Text] [Related]
6. Palonosetron versus other 5-HT(3) receptor antagonists for prevention of chemotherapy-induced nausea and vomiting in patients with cancer on chemotherapy in a hospital outpatient setting.
Balu S; Buchner D; Craver C; Gayle J
Clin Ther; 2011 Apr; 33(4):443-55. PubMed ID: 21635990
[TBL] [Abstract][Full Text] [Related]
7. Impact of adjuvant lorazepam with granisetron on chemotherapy-induced nausea and vomiting in pediatric patients with acute lymphoblastic leukemia.
Ono A; Kishimoto K; Hasegawa D; Goldman RD; Kosaka Y
Support Care Cancer; 2019 Mar; 27(3):895-899. PubMed ID: 30066198
[TBL] [Abstract][Full Text] [Related]
8. 5-Hydroxytryptamine-3 receptor antagonist and dexamethasone as prophylaxis for chemotherapy-induced nausea and vomiting during moderately emetic chemotherapy for solid tumors: a multicenter, prospective, observational study.
Matsui R; Suzuki K; Takiguchi T; Nishio M; Koike T; Hayashi T; Seto T; Kogure Y; Nogami N; Fujiwara K; Kaneda H; Harada T; Shimizu S; Kimura M; Kenmotsu H; Shimokawa M; Goto K
BMC Pharmacol Toxicol; 2020 Oct; 21(1):72. PubMed ID: 33023657
[TBL] [Abstract][Full Text] [Related]
9. Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood.
Phillips RS; Gopaul S; Gibson F; Houghton E; Craig JV; Light K; Pizer B
Cochrane Database Syst Rev; 2010 Sep; (9):CD007786. PubMed ID: 20824866
[TBL] [Abstract][Full Text] [Related]
10. Acupuncture against chemotherapy-induced nausea and vomiting in pediatric oncology. Interim results of a multicenter crossover study.
Reindl TK; Geilen W; Hartmann R; Wiebelitz KR; Kan G; Wilhelm I; Lugauer S; Behrens C; Weiberlenn T; Hasan C; Gottschling S; Wild-Bergner T; Henze G; Driever PH
Support Care Cancer; 2006 Feb; 14(2):172-6. PubMed ID: 16021478
[TBL] [Abstract][Full Text] [Related]
11. Changes in Antiemetic Overuse in Response to Choosing Wisely Recommendations.
Encinosa W; Davidoff AJ
JAMA Oncol; 2017 Mar; 3(3):320-326. PubMed ID: 27632203
[TBL] [Abstract][Full Text] [Related]
12. Acute and delayed nausea and emesis control in pediatric oncology patients.
Holdsworth MT; Raisch DW; Frost J
Cancer; 2006 Feb; 106(4):931-40. PubMed ID: 16404740
[TBL] [Abstract][Full Text] [Related]
13. Safety of clinical practice guideline-recommended antiemetic agents for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric patients: a systematic review and meta-analysis.
Patel P; Paw Cho Sing E; Dupuis LL
Expert Opin Drug Saf; 2019 Feb; 18(2):97-110. PubMed ID: 30640557
[TBL] [Abstract][Full Text] [Related]
14. Transferability to clinical practice of the results of controlled clinical trials: the case of antiemetic prophylactic treatment for cancer chemotherapy-induced nausea and vomiting. Italian Group for Antiemetic Research.
Ann Oncol; 1998 Jul; 9(7):759-65. PubMed ID: 9739443
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of a single-day three-drug regimen of dexamethasone, palonosetron, and aprepitant for the prevention of acute and delayed nausea and vomiting caused by moderately emetogenic chemotherapy.
Grunberg SM; Dugan M; Muss H; Wood M; Burdette-Radoux S; Weisberg T; Siebel M
Support Care Cancer; 2009 May; 17(5):589-94. PubMed ID: 19037667
[TBL] [Abstract][Full Text] [Related]
16. Palonosetron versus other 5-HT₃ receptor antagonists for prevention of chemotherapy-induced nausea and vomiting in patients with hematologic malignancies treated with emetogenic chemotherapy in a hospital outpatient setting in the United States.
Craver C; Gayle J; Balu S; Buchner D
J Med Econ; 2011; 14(3):341-9. PubMed ID: 21542674
[TBL] [Abstract][Full Text] [Related]
17. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
18. Creation of a chemotherapy-induced nausea/vomiting dashboard to improve outcomes for pediatric cancer patients.
Walsh AM; Hess J; Rees M; Wetmore C; Vadiya V
Support Care Cancer; 2021 Mar; 29(3):1549-1555. PubMed ID: 32734390
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the compliance with antiemetic guidelines for prevention of chemotherapy-induced nausea and vomiting in patients with hematologic malignancy.
Uchida M; Nakamura T; Shima T; Mori Y; Yoshimoto G; Kato K; Shimokawa M; Hosohata K; Miyamoto T; Akashi K
Pharmazie; 2019 Apr; 74(4):250-254. PubMed ID: 30940311
[TBL] [Abstract][Full Text] [Related]
20. Antiemetic therapy for multiple-day chemotherapy and additional topics consisting of rescue antiemetics and high-dose chemotherapy with stem cell transplant: review and consensus statement.
Einhorn LH; Grunberg SM; Rapoport B; Rittenberg C; Feyer P
Support Care Cancer; 2011 Mar; 19 Suppl 1():S1-4. PubMed ID: 20505956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
